Consistent with this, increased levels of OPN in the CSF were found to distinguish AD patients from those with frontotemporal dementia (FTD), and correlated with the severity of cognitive impairment, consistent with OPN as a prognostic indicator of AD progression [44]. The gene discussed is SPP1; the disease is Alzheimer disease.